Physician profile
Robin Cooper
NPI 1558746701
$1,819.27
in general payments reported to CMS, 2019-2025
9 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2023: $174 · 2024: $458 · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,644.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $470.56 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $310.26 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $293.54 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.19 | 2025 | Jardiance |
| Abbott Laboratories | $147.95 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Glaxosmithkline, LLC. | $130.18 | 2025 | Nucala |
| Scpharmaceuticals INC. | $111.66 | 2025 | |
| Amgen INC. | $75.33 | 2023 | Repatha |
| Novo Nordisk INC | $49.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.